Are you Dr. Chappell?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000
Summary
- Dr. James Chappell, MD is a board certified pathologist in Nashville, Tennessee. He is currently licensed to practice medicine in Tennessee. He is an Assistant Professor at Microbiology and Immunology.
Education & Training
Vanderbilt University School of MedicineClass of 2001
Certifications & Licensure
TN State Medical License 2003 - 2027
American Board of Pathology Clinical Pathology
Publications & Presentations
PubMed
- Effectiveness of mRNA COVID-19 vaccines and hybrid immunity in preventing SARS-CoV-2 infection and symptomatic COVID-19 among adults in the United States.Leora R Feldstein, Jasmine Ruffin, Ryan E Wiegand, Craig B Borkowf, Jade James-Gist
The Journal of Infectious Diseases. 2025-01-08 - 1 citationsAssessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses - IVY Network, September 1, 2022-March 30, 2023.Nathaniel M Lewis, Elizabeth J Harker, Aleda Leis, Yuwei Zhu, H Keipp Talbot
Vaccine. 2025-01-01 - Antiviral Use Among Children Hospitalized With Laboratory-Confirmed Influenza Illness: A Prospective, Multicenter Surveillance Study.James W Antoon, Justin Z Amarin, Olla Hamdan, Tess Stopczynski, Laura S Stewart
Clinical Infectious Diseases. 2024-12-17
Press Mentions
Early RSV Infection Linked to Significantly Increased Risk of Asthma in Children, Study Finds – ScienceDailyApril 25th, 2023- RSV Infection in the First Year of Life Associated with Increased Risk of Childhood AsthmaApril 24th, 2023
Tennessee Family, Hospital Celebrate as Last COVID-19 Patient Is Released After 53-Day FightMay 13th, 2020
